189 results on '"Zhang, Shu-Yun"'
Search Results
2. Associations of exposure to metals with total and allergen-specific IgE: An NHANES analysis (2005–2006)
3. 6PPD and its metabolite 6PPDQ induce different developmental toxicities and phenotypes in embryonic zebrafish
4. Mechanism of the Visible-Light-Promoted C(sp3)–H Oxidation via Uranyl Photocatalysis.
5. Case report: Recurrent pontine stroke and leukoencephalopathy in a patient with de novo mutation in COL4A1
6. Associations of exposure to metals with total and allergen-specific IgE: An NHANES analysis (2005–2006)
7. Design of amidobenzimidazole STING receptor agonists with systemic activity
8. Mechanism of the Visible-Light-Promoted C(sp3)–H Oxidation via Uranyl Photocatalysis
9. Stiffness changes in internal rotation muscles of the shoulder and its influence on hemiplegic shoulder pain
10. Supplementary Data from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
11. Supplementary figure 2 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
12. Supplementary figure 1 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
13. Supplementary tables S1-S6 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
14. Data from Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
15. Supplementary Figure 2 from Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic BRAF by the Kinase Inhibitor SB-590885
16. Supplementary Figure 1 from Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic BRAF by the Kinase Inhibitor SB-590885
17. Supplementary Figures 1-3 from Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
18. Data from Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
19. Supplementary Material from Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
20. Supplementary Figure 3 from Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic BRAF by the Kinase Inhibitor SB-590885
21. Supplementary Figure 2 from Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
22. Supplementary Methods and Figure Legends 1-2 from Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
23. Cold stress during the perinatal period leads to developmental and neurobehavioral toxicity in zebrafish larvae
24. Photocatalytic oxidative cleavage of aryl alkenes C=C bonds via uranyl cation
25. Constitutive androstane receptor (CAR) mediates pyrene-induced inflammatory responses in mouse liver, with increased serum amyloid A proteins and Th17 cells.
26. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression
27. Increased Magnetic Susceptibility in the Deep Gray Matter Nuclei of Wilson's Disease: Have We Been Ignoring Atrophy?
28. Increased Stiffness of the Superficial Cervical Extensor Muscles in Patients With Cervicogenic Headache: A Study Using Shear Wave Elastography
29. Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity
30. An Update on Nondopaminergic Treatments for Motor and Non-motor symptoms of Parkinson’s disease
31. Improvement on transient stability and power quality of wind power integrated system based on STATCOM-PSS control
32. Styrene Trimer May Increase Thyroid Hormone Levels via Down-Regulation of the Aryl Hydrocarbon Receptor (AhR) Target Gene UDP-Glucuronosyltransferase
33. Bisphenol A may cause testosterone reduction by adversely affecting both testis and pituitary systems similar to estradiol
34. Chrysene, a four-ring polycyclic aromatic hydrocarbon, induces hepatotoxicity in mice by activation of the aryl hydrocarbon receptor (AhR)
35. Numerical Computation of Pressure Gradient for The Flow of Power-Law Fluid in Annulus with Inner Cylinder Executing A Planetary Motion
36. Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression
37. Abstract 2220: Non-clinical tumor models reveal broad combination potential of ICOS agonist antibodies
38. Study on Mechanical Properties of Submunition’s Ribbon Straightening Section
39. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I–αβTCR interaction and become IL-10-producing active regulatory cells
40. Permethrin May Disrupt Testosterone Biosynthesis via Mitochondrial Membrane Damage of Leydig Cells in Adult Male Mouse
41. Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice
42. A New Evolutionary Machine Learning Approach for Identifying Pyrene Induced Hepatotoxicity and Renal Dysfunction in Rats
43. Study on Mechanical Properties of Submunition's Ribbon Straightening Section.
44. Identification of hepatotoxicity and renal dysfunction of pyrene in adult male rats
45. Synergy of TLR4 agonist GSK1795091, an innate immune activator, with agonistic antibody against co-stimulatory immune checkpoint molecule OX40 in cancer immunotherapy.
46. Abstract 1637: ICOS agonism induces potent immune activation and anti-tumor response in non-clinical models
47. Abstract IA22: Targeting inducible T cell co-stimulator (ICOS) promotes effector T cell function and antitumor response
48. Upregulation of humanCYP2C9expression by Bisphenol A via estrogen receptor alpha (ERα) and Med25
49. Abstract A149: Evaluating immune contexture in syngeneic mouse models of cancer
50. Pyrene is a Novel Constitutive Androstane Receptor (CAR) Activator and Causes Hepatotoxicity by CAR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.